Zoledronic acid for all patients with newly diagnosed multiple myeloma?

Lancet Oncol. 2011 Aug;12(8):711-2. doi: 10.1016/S1470-2045(11)70178-4. Epub 2011 Jul 21.
No abstract available

Publication types

  • Comment

MeSH terms

  • Bone Density Conservation Agents / therapeutic use*
  • Clodronic Acid / therapeutic use*
  • Diphosphonates / therapeutic use*
  • Female
  • Fractures, Spontaneous / prevention & control*
  • Humans
  • Imidazoles / therapeutic use*
  • Male
  • Multiple Myeloma / drug therapy*
  • Zoledronic Acid

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Clodronic Acid
  • Zoledronic Acid